Press release
Global AI-based Clinical Trial Solution Providers Market Analysis of Key Vendors Such as Antidote Technologies, Inc., AiCure, LLC, Deep 6 AI, Deep Lens Inc., Innoplexus,MEDIAN Technologies, Mendel.ai, Phesi, Unlearn.AI, Inc. and Trials.ai among others.
Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-ai-based-clinical-trial-solution-providers-market/#request-for-tocproposal
According to the latest research by InsightAce Analytic, the global market is expected to record a promising CAGR during the period of 2020-2028. The process, clinical trials are a very crucial that enable both innovators and regulators to assess the efficacy of a candidate drug. The successfully developing a novel therapeutic intervention required around 10 years of time and cost around USD 2.5 billion, However, use of technology like artificial intelligent in clinical trial help to save huge amount of money as well as time.
Increasing number of collaborations to applying Artificial Intelligence (AI) in clinical trials aims to reduce time as well expenditure during clinical developmental phases expected to create the lucrative growth in market near the future.
Furthermore, raising artificial intelligence based startups in clinical trials sector have significantly growth in recent years and trend expected to be same for forecast period. Additionally, Regulators around the world have released guideline that encourage biopharma companies to use Real world evidence strategies. For instance, US FDA has passed the 21st Century Cures Act, in 2016, that was designed to help bring new innovations and advances to patients more efficiently and faster.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-ai-based-clinical-trial-solution-providers-market/#request-for-tocproposal
The AI-based clinical trial solution providers market is fragmented with presence of many players that operates in AI-based clinical trial solution providers in local as well as international market.
Global AI-based Clinical Trial Solution Providers Market reports cover clinical trial/pipeline prominent players like Antidote Technologies, Inc., AiCure, LLC, Deep 6 AI, Deep Lens Inc., Innoplexus, Intelligencia.ai, MEDIAN Technologies, Mendel.ai, Phesi, Saama Technologies, Unlearn.AI, Inc. and Trials.ai among others.
Curious about this latest version of report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-ai-based-clinical-trial-solution-providers-market/#request-for-tocproposal
Market Segments
Global AI-based Clinical Trial Solution Providers Market by Target Therapeutic Area Revenue (US$ Mn) Forecast 2020-2028
o Cardiovascular Disorders
o CNS Disorders
o Infectious Disorders
o Metabolic Disorders
o Oncological Disorders
o Other Disorders
Global AI-based Clinical Trial Solution Providers Market Based on Trial Phase Revenue (US$ Mn) Forecast 2020-2028
o Early Phase 1
o Phase 1
o Phase 2
o Phase 3
o Phase 4
Global AI-based Clinical Trial Solution Providers Market Based on End Users (US$ Mn) Forecast 2020-2028
o Pharmaceutical Companies
o Academia and Other Users
Global AI-based Clinical Trial Solution Providers Market Based on Region Revenue (US$ Mn) Forecast 2020-2028
Europe Revenue (US$ Mn) Forecast 2020-2028
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
North America Revenue (US$ Mn) Forecast 2020-2028
o U.S.
o Canada
Asia Pacific Revenue (US$ Mn) Forecast 2020-2028
Latin America Revenue (US$ Mn) Forecast 2020-2028
Middle East & Africa Revenue (US$ Mn) Forecast 2020-2028
Why should buy this report:
To receive a comprehensive analysis of the prospects for Global AI-based Clinical Trial Solution Providers Market
To receive industry overview and future trends AI-based clinical trial solution providers market
To analyze the AI-based clinical trial solution providers market drivers and challenges
To get information on AI-based clinical trial solution providers size value/revenue (US$ Mn) forecast till 2028
Major Investments, Mergers & Acquisition in AI-based clinical trial solution providers industry
For More Information @ https://www.insightaceanalytic.com/report-details/global-ai-based-clinical-trial-solution-providers-market/#request-for-tocproposal
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global AI-based Clinical Trial Solution Providers Market Analysis of Key Vendors Such as Antidote Technologies, Inc., AiCure, LLC, Deep 6 AI, Deep Lens Inc., Innoplexus,MEDIAN Technologies, Mendel.ai, Phesi, Unlearn.AI, Inc. and Trials.ai among others. here
News-ID: 2128736 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to the…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
